MHRA, United Kingdom
Head – Biosimilars Section, Biotherapeutics and Advanced Therapies Group, R&D, Science and Research, MHRA, Blanche Lane, South Mimms, Potters Bar, HERTS, EN6 3QG
Meenu heads the Biosimilars team in the R&D Biotherapeutics and Advanced Therapies Group, Science and Research division of the MHRA, UK. Main interests are the development and application of assays – potency, bioanalytical (incl anti-drug antibody assays), biosimilar medicines, predicting adverse effects of biotherapeutics and the unwanted immunogenicity of biotherapeutics. She has developed reference standards for various therapeutics, anti-drug antibodies, written numerous publications and given presentations at international/national conferences. She works closely with different pharmacopoeias, medicines control laboratories, professional societies and the WHO. Previously, she has participated Biologics Working Party and the Biosimilar medicines Working Party meetings at EMA and was involved in the drafting of the EMA guidelines (e.g., immunogenicity assessment). She also supports assessors in the review of bioanalytical assays for product approval. She reviews manuscripts for scientific journals, has served on the editorial board of journals and currently serves as an associate editor for Biologicals.